Skip to main content
Caplight Logo









ZBiotics

ZBiotics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://zbiotics.com/

Last Round

Series A

Aug 27, 2024

Est. Valuation

$1.71M

Total Funding Raised

$17.7M

Company Overview

ZBiotics is a biotechnology company that develops genetically engineered probiotics designed to improve human health by addressing everyday biological challenges, such as breaking down alcohol byproducts.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

synthetic biologygenetically engineered probiotichangover curepre-alcohol probioticfunctional beverageDTCdirect-to-consumergut healthbioengineered bacteriaacetaldehyde breakdownhangover preventionsynbioprobiotic supplementconsumer healthsubscription supplement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZBiotics Comparables

Compare ZBiotics with similar companies based on industry and business-model similarity.

ZBiotics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
More Labs
84%
de Faire Medical AB
80%
No Days Wasted
80%

ZBiotics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 27, 2024
SeedMar 12, 2020
AcceleratorAug 7, 2018
SeedMar 21, 2018

Key People

Founding team and executive leadership

Zachary Abbott

Founder, CEO

Founding Team

ZBiotics Investors

Notable investors and investment history

ZBiotics investors
InvestorRounds
Utopian VenturesSeed
Oyster VenturesSeed
Access CapitalSeries A
Seamless CapitalSeries A
BABEL VenturesSeed
Babel VenturesSeed
Seamless CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2024

    $12M round completed.

  • Jan 1, 2024

    Sugar-to-Fiber, a probiotic drink mix, is launching in 2024.

ZBiotics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ZBiotics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ZBiotics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range63
Year Founded2016
Last FundingAug 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?